osimertinib
pfizer,astrazeneca
['tagrisso', 'astrazeneca', 'pfizer']
sfbn feed: closing asco: astrazeneca s very special meeting, more car-t survival data and pfizer s parp play: dramatically positive trial data for astrazeneca s tagrisso capped an important ... #bayarea #biotech 
San Francisco Biotechnology News and Events, follow jobs at @sfbnjobs